Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Brigham and Women's Hospital located at 75 Francis St, Boston, MA, 02115 & includes data from NPIs 1790717650
Dexur analyzed Q4 2016 (October to December 2016) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Brigham and Women's Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,701 | 3,516 | ||||||||||
| Surgical | 1,572 | 1,520 | ||||||||||
| Non Surgical | 2,129 | 1,996 | ||||||||||
| Cardiovascular | 808 | 768 | ||||||||||
| General Surgery | 527 | 504 | ||||||||||
| Orthopedics | 400 | 389 | ||||||||||
| Gastroenterology & Endocrinology | 367 | 355 | ||||||||||
| General Medicine | 305 | 273 | ||||||||||
| Pulmonology | 276 | 256 | ||||||||||
| Neurology | 249 | 237 | ||||||||||
| Urology | 226 | 221 | ||||||||||
| Oncology & Hematology | 210 | 188 | ||||||||||
| Spine | 102 | 102 | ||||||||||
| Colorectal | 78 | 74 | ||||||||||
| Obstetrics & Gynecology | 54 | 54 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 50 | 50 | ||||||||||
| Psychiatry & Mental Disorders | 34 | 30 | ||||||||||
| Dermatology | 15 | 15 |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Cardiac Defibrillator Implant | ||||||||||||
| Aortic And Heart Assist Procedures | ||||||||||||
| Hypertension | ||||||||||||
| Other Cardiothoracic Procedures | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Other Circulatory O.R. Procedures | ||||||||||||
| DRG 264: OTHER CIRCULATORY SYSTEM O.R. PROCEDURES | ||||||||||||
| Atherosclerosis |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Chest Procedures | ||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 163: MAJOR CHEST PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 026: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ventricular Shunt Procedures | ||||||||||||
| DRG 033: VENTRICULAR SHUNT PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
| Allogeneic Bone Marrow Transplant | ||||||||||||
| DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extracranial Procedures | ||||||||||||
| Peritoneal Adhesiolysis | ||||||||||||
| Other Digestive System O.R. Procedures | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| Wound Debridements For Injuries | ||||||||||||
| Hernia Procedures | ||||||||||||
| Lymphoma And Non-Acute Leukemia With Other Procedure |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| DRG 517: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
| DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Connective Tissue Disorders | ||||||||||||
| DRG 545: CONNECTIVE TISSUE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
| Amputation For Circulatory System Disorders Except Upper Limb And Toe | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cholecystectomy | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Disorders Of Biliary Tract | ||||||||||||
| DRG 445: DISORDERS OF THE BILIARY TRACT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Endocrine Disorders |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment | ||||||||||||
| DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Postoperative And Post-Traumatic Infections | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||
| Respiratory Signs And Symptoms | ||||||||||||
| DRG 204: RESPIRATORY SIGNS AND SYMPTOMS | ||||||||||||
| Major Chest Trauma |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Major Male Pelvic Procedures | ||||||||||||
| DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Bladder Procedures | ||||||||||||
| DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nervous System Neoplasms | ||||||||||||
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Neoplasms | ||||||||||||
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Digestive Malignancy | ||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
| Chemotherapy | ||||||||||||
| Acute Leukemia Without Major Procedure |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators | ||||||||||||
| Spinal Procedures | ||||||||||||
| DRG 029: SPINAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) OR SPINAL NEUROSTIMULATORS |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy | ||||||||||||
| DRG 737: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures | ||||||||||||
| DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Massachusetts Total Hospitalizations (Oct 2016 to Dec 2016) | Massachusetts Total Hospitalizations After Exclusion | Massachusetts Total Users | Massachusetts SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcohol/Drug Abuse Or Dependence |